Author

Kunihiro Matsushita

Professor of Epidemiology and Medicine, Johns Hopkins University - Cited by 86,325 - Cardiovascular Disease - Chronic Kidney Disease - Risk Prediction

Biography

Dr. Kunihiro Matsushita is an associate professor of medicine at the Johns Hopkins University School of Medicine. His research focuses on cardiovascular epidemiology. He is an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. Through his clinical experience as an interventional cardiologist, Dr. Matsushita was first interested in diabetes as a key risk factor for coronary heart disease and its antecedent, obesity. His early research area of interest was the epidemiological relationship among insulin resistance, adipokines, inflammatory markers and cardiovascular risk
Title
Cited by
Year
Epidemiology of peripheral artery disease and polyvascular disease
AW Aday, K MatsushitaCirculation research 128 (12), 1818-1832, 2021202
147
2021
Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association
MH Criqui, K Matsushita, V Aboyans, CN Hess, CW Hicks, TW Kwan, ...Circulation 144 (9), e171-e191, 2021202
145
2021
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions
European Heart Journal 42 (25), 2455-2467, 2021202
79
2021
Chronic kidney disease testing among primary care patients with type 2 diabetes across 24 US health care organizations
N Stempniewicz, JA Vassalotti, JK Cuddeback, E Ciemins, A Storfer-Isser, ...Diabetes care 44 (9), 2000-2009, 2021202
45
2021
Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium
JI Shin, AR Chang, ME Grams, J Coresh, SH Ballew, A Surapaneni, ...Hypertension 78 (4), 1042-1052, 2021202
32
2021
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
KL Johansen, PS Garimella, CW Hicks, PA Kalra, DM Kelly, S Martens, ...Kidney international 100 (1), 35-48, 2021202
26
2021
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients …
KU Eckardt, R Agarwal, YM Farag, AG Jardine, Z Khawaja, MJ Koury, ...Nephrology Dialysis Transplantation 36 (11), 2039-2048, 202
21
2021
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans
M Minamisawa, RM Inciardi, B Claggett, SAM Cuddy, CC Quarta, ...European journal of heart failure 23 (8), 1290-1295, 2021202
18
2021
Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts
CW Hicks, D Wang, BG Windham, K Matsushita, E SelvinScientific reports 11 (1), 19159, 2021202
16
2021
Association of left ventricular systolic function with incident heart failure in late life
AMR Jensen, R Zierath, B Claggett, H Skali, SD Solomon, K Matsushita, ...JAMA cardiology 6 (5), 509-520, 2021202
13
2021
Upper reference limits for high-sensitivity cardiac troponin T and N-terminal fragment of the prohormone brain natriuretic peptide in patients with CKD
N Bansal, LR Zelnick, CM Ballantyne, PHM Chaves, RH Christenson, ...American Journal of Kidney Diseases 79 (3), 383-392, 2022202
10
2022
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: design and baseline characteristics
GM Chertow, PE Pergola, R Agarwal, GA Block, YMK Farag, AG Jardine, ...American heart journal 235, 1-11, 2021202
10
2021
Estimation of the global gap in clinic visits for hypertension care between patient need and physician capacity
D Neupane, Y Gao, Y Feng, K Matsushita, LJ AppelHypertension 78 (3), 77-786, 2021202
9
2021
Effects of different rest period durations prior to blood pressure measurement: the best rest trial
TM Brady, J Charleston, J Ishigami, ER Miller III, K Matsushita, LJ AppelHypertension 78 (5), 1511-151, 2021202
9
2021
Chronic kidney disease measures for cardiovascular risk prediction
Y Mok, SH Ballew, K MatsushitaAtherosclerosis 335, 110-118, 2021202
9
2021
The aortic-femoral arterial stiffness gradient: an atherosclerosis risk in communities (ARIC) study
K Stone, S Fryer, ML Meyer, A Kucharska-Newton, J Faulkner, G Zieff, ...Journal of hypertension 3 (7), 1370, 2021202
9
2021
Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: the atherosclerosis risk in communities (ARIC) study
K Stone, S Fryer, J Faulkner, ML Meyer, K Heffernan, ...Atherosclerosis 340, 53-60, 2022202
8
2022
Echocardiographic measures and subsequent decline in kidney function in older adults: the Atherosclerosis Risk in Communities Study
J Ishigami, L Mathews, M Hishida, DW Kitzman, J Coresh, SD Solomon, ...European Heart Journal-Cardiovascular Imaging 23 (2), 23-293, 2022202
8
2022
Clinical applications measuring arterial stiffness: An expert consensus for the application of cardio-ankle vascular index
MJ Budoff, B Alpert, JA Chirinos, B Fernhall, N Hamburg, K Kario, I Kullo, ...American journal of hypertension 35 (5), 441-453, 2022202
8
2022
Time-updated changes in estimated GFR and proteinuria and major adverse cardiac events: findings from the Chronic Renal Insufficiency Cohort (CRIC) study
JB Cohen, W Yang, L Li, X Zhang, Z Zheng, P Orlandi, N Bansal, R Deo, ...American Journal of Kidney Diseases 9 (1), 36-44. e1, 2022202
7
2022

Referred From: https://scholar.google.com/citations?user=Z42qYtkAAAAJ&hl=en

Cited by
Citations 86325
h-index 87
i10-index 289
Recommended Journals
Open Access Journals